SCHEMBL17791103

SCHEMBL17791103

Cc1ccc(Oc2cccc(C(F)(F)F)c2C(=O)Nc2cccc(S(N)(=O)=O)c2)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16408385 0.90 — —
SCHEMBL17791073 0.86 — —
SCHEMBL16408386 0.86 — —
SCHEMBL17791072 0.85 — —
SCHEMBL16408300 0.85 — —
SCHEMBL16408383 0.84 — —
SCHEMBL16408390 0.83 — —
SCHEMBL17791111 0.83 — —
SCHEMBL16408387 0.83 — —
SCHEMBL16408243 0.83 SCN8A (0.64) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20160152561-A1 SULFONAMIDES AS MODULATORS OF SODIUM CHANNELS VERTEX PHARMACEUTICALS (SAN DIEGO) LLC 2016-06-02 — — US disclosed
Send feedback